{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:51:03Z","timestamp":1790279463551,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ad.2018.10.020","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T16:13:54Z","timestamp":1551716034000},"page":"279-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Asociaci\u00f3n entre la hidradenitis supurativa y el s\u00edndrome metab\u00f3lico: Revisi\u00f3n sistem\u00e1tica y metaan\u00e1lisis"],"prefix":"10.1016","volume":"110","author":[{"given":"M.J.M.","family":"Rodr\u00edguez-Zu\u00f1iga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Garc\u00eda-Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Ortega-Loayza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 Suppl 1","key":"10.1016\/j.ad.2018.10.020_bib0210","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","article-title":"Hidradenitis suppurativa: Epidemiology and scope of the problem","volume":"73","author":"Jemec","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0215","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ad.2015.06.004","article-title":"An update on hidradenitis suppurativa (Part I): Epidemiology clinical aspects, and definition of disease severity","volume":"106","author":"Martorell","year":"2015","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2018.10.020_bib0220","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.2174\/1381612811319270002","article-title":"Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome","volume":"19","author":"Wang","year":"2013","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.ad.2018.10.020_bib0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/dc06-1414","article-title":"International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes","volume":"30","author":"Lorenzo","year":"2007","journal-title":"Diabetes Care."},{"key":"10.1016\/j.ad.2018.10.020_bib0230","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLOS ONE."},{"key":"10.1016\/j.ad.2018.10.020_bib0235","article-title":"Association of psoriasis and metabolic syndrome in Latin America: A systematic review and meta-analysis","author":"Rodriguez-Zuniga","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2018.10.020_bib0240","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: A systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2753.2010.01444.x","article-title":"Combining adjusted and unadjusted findings in mixed research synthesis","volume":"17","author":"Voils","year":"2011","journal-title":"J Eval Clin Pract."},{"key":"10.1016\/j.ad.2018.10.020_bib0250","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: A little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2018.10.020_bib0255","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: A proposal for reporting Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA."},{"key":"10.1016\/j.ad.2018.10.020_bib0260","unstructured":"World_Health_Organization. Part 1: Diagnosis and classification of diabetes mellitus. 1999. En: Definition, diagnosis and classification of diabetes mellitus and its complications [Internet]. Genova [consultado 31 May 2017]. Disponible en: http:\/\/apps.who.int\/iris\/bitstream\/10665\/66040\/1\/WHO_NCD_NCS_99.2.pdf"},{"key":"10.1016\/j.ad.2018.10.020_bib0265","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"10.1016\/j.ad.2018.10.020_bib0270","unstructured":"International-Diabetes-Federation. The IDF consensus worldwide definition of the metabolic syndrome 2005; 2016 [consultado 31 May 2017]. Disponible en: http:\/\/www.idf.org\/webdata\/docs\/IDF_Meta_def_final.pdf"},{"key":"10.1016\/j.ad.2018.10.020_bib0275","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation."},{"issue":"Pt A","key":"10.1016\/j.ad.2018.10.020_bib0280","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials."},{"key":"10.1016\/j.ad.2018.10.020_bib0285","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med."},{"key":"10.1016\/j.ad.2018.10.020_bib0290","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ."},{"key":"10.1016\/j.ad.2018.10.020_bib0295","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): Development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg."},{"key":"10.1016\/j.ad.2018.10.020_bib0300","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0305","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions: The Cochrane Collaboration; 2011 [consultado 10 Jun 2016]. Disponible en: http:\/\/handbook.cochrane.org\/front_page.htm"},{"key":"10.1016\/j.ad.2018.10.020_bib0310","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The\u201dpsoriatic march\u201d: A concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0415","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/bjd.14013","article-title":"Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission","volume":"174","author":"Coimbra","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0320","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjmed.2014.08.008","article-title":"Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities","volume":"127","author":"Shlyankevich","year":"2014","journal-title":"Am J Med."},{"key":"10.1016\/j.ad.2018.10.020_bib0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.det.2015.08.004","article-title":"Inflammatory mechanisms in hidradenitis suppurativa","volume":"34","author":"Kelly","year":"2016","journal-title":"Dermatol Clin."},{"key":"10.1016\/j.ad.2018.10.020_bib0330","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/ijd.12550","article-title":"Hidradenitis suppurativa: The role of immune dysregulation","volume":"53","author":"Kelly","year":"2014","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0335","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamadermatol.2014.691","article-title":"Health care utilization patterns and costs for patients with hidradenitis suppurativa","volume":"150","author":"Kirby","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2018.10.020_bib0420","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/bjd.14976","article-title":"High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics","volume":"176","author":"Desai","year":"2017","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0345","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: Results from 2case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0350","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00403-015-1596-5","article-title":"Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients","volume":"307","author":"Riis","year":"2015","journal-title":"Arch Dermatol Res."},{"key":"10.1016\/j.ad.2018.10.020_bib0355","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaad.2015.08.052","article-title":"Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)","volume":"73","author":"Hessam","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0360","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0365","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0370","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/09546634.2016.1187707","article-title":"Characterization of obesity rates for dermatologic ambulatory office visits to United States physicians","volume":"28","author":"Fleischer","year":"2017","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2018.10.020_bib0375","first-page":"e14779","article-title":"Active smoking and risk of metabolic syndrome: A meta-analysis of prospective studies","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.ad.2018.10.020_bib0380","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2016.07.041","article-title":"The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study","volume":"76","author":"Denny","year":"2017","journal-title":"J Am Acad Dermatol."},{"issue":"5 Suppl 1","key":"10.1016\/j.ad.2018.10.020_bib0385","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2015.07.051","article-title":"Hidradenitis suppurativa in the pediatric population","volume":"73","author":"Liy-Wong","year":"2015","journal-title":"J Am Acad Dermatol."},{"issue":"Suppl 2","key":"10.1016\/j.ad.2018.10.020_bib0390","first-page":"51","article-title":"Epidemiological, clinical and therapeutic aspects in special situations: Hidradenitis suppurativa in paediatric patients","volume":"107","author":"Rodriguez Bandera","year":"2016","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2018.10.020_bib0395","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaad.2014.11.017","article-title":"Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement","volume":"72","author":"Deckers","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0400","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: A comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0405","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40272-014-0091-3","article-title":"Hidradenitis suppurativa in children and adolescents: A review of treatment options","volume":"16","author":"Mikkelsen","year":"2014","journal-title":"Paediatr Drugs."},{"key":"10.1016\/j.ad.2018.10.020_bib0410","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.puhe.2016.09.001","article-title":"Metabolic syndrome in adolescents: definition based on regression of IDF adult cut-off points","volume":"141","author":"Benmohammed","year":"2016","journal-title":"Public Health."},{"key":"10.1016\/j.ad.2018.10.020_bib0425","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2018.10.020_bib0430","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jdv.14076","article-title":"Assessment of subclinical atherosclerosis in hidradenitis suppurativa","volume":"31","author":"Pascual","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000173101930002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000173101930002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:08:18Z","timestamp":1757552898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000173101930002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S000173101930002X"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2018.10.020","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asociaci\u00f3n entre la hidradenitis supurativa y el s\u00edndrome metab\u00f3lico: Revisi\u00f3n sistem\u00e1tica y metaan\u00e1lisis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2018.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}